NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Noetik

Noetik

Private
South San Francisco, CaliforniaHealthcare & Life Scienceshttps://www.noetik.ai/

Last Round

Grant

Mar 5, 2025

Total Funding Raised

$54.25M

Company Overview

Noetik is a biotechnology company that develops AI-driven platforms for cancer immunotherapy discovery and development.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine, Medical AI

Business Model

B2B

Customer Profile

Subscription SaaS, Data as a Service, Services & Consulting

AI Layer

Foundation

Keywords

foundation modelsvirtual cell biologyAI drug discoverycancer research AIspatial oncologybiotech AIspatial biologypredictive biomarkersdrug discoveryAI-driven therapeuticsprecision medicineAI pathologyclinical trial optimizationin silico biologymultimodal spatial data

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Noetik Comparables

Compare Noetik with similar companies based on industry and business-model similarity.

Noetik comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Tahoe Therapeutics
85%
Bioptimus
83%
GenBio AI
82%

Noetik Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantMar 5, 2025
Series AAug 28, 2024
SeedSep 7, 2023

Key People

Founding team and executive leadership

Ron Alfa

Co-Founder CEO

Founding Team

Noetik Investors

Notable investors and investment history

Noetik investors
InvestorRounds
Khosla VenturesSeries A
Zetta Venture PartnersSeries A, Seed
The Roddenberry FoundationGrant
Intermountain VenturesSeries A, Seed
Catalio Capital ManagementSeries A, Seed
EPIC VenturesSeries A, Seed
Breakout VenturesSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 18, 2025

    Partnering with Agenus to develop predictive biomarkers for immuno-oncology.

  • Apr 10, 2025

    Dr. Emily Corse appointed EVP of Therapeutics.

Noetik Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Noetik Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Noetik's valuation, stock price, and market status.

Firmographic Details

HeadquartersSouth San Francisco, California
Employee Range49
Year Founded2022
Last FundingMar 5, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.